Johnson & Johnson (JNJ) Meets EPS Estimate, Beats on Revenue; Offers FY Guidance

Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.46, in line with the analyst estimate of $2.46. Revenue for the quarter came in at $24.6 billion versus the consensus estimate of $24.15 billion.

GUIDANCE:

Johnson & Johnson sees FY2026 EPS of $11.43-$11.63, versus the consensus of $11.49. Johnson & Johnson sees FY2026 revenue of $100-101 billion, versus the consensus of $98.9 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Village Super Market (VLGEA) Declares $0.25 Quarterly Dividend; 2.4% Yield
• In memo, Meta says it plans to crack down on employee token use as AI costs soar - The Information